Deutsche Bank’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.61M | Sell |
195,196
-8,926
| -4% | -$257K | ﹤0.01% | 1189 |
|
2025
Q1 | $6.85M | Sell |
204,122
-7,192
| -3% | -$241K | ﹤0.01% | 1125 |
|
2024
Q4 | $10.8M | Sell |
211,314
-4,803
| -2% | -$246K | ﹤0.01% | 998 |
|
2024
Q3 | $11M | Buy |
216,117
+12,228
| +6% | +$625K | ﹤0.01% | 984 |
|
2024
Q2 | $9.13M | Buy |
203,889
+134,282
| +193% | +$6.01M | ﹤0.01% | 1027 |
|
2024
Q1 | $3.26M | Sell |
69,607
-10,820
| -13% | -$506K | ﹤0.01% | 1429 |
|
2023
Q4 | $2.86M | Buy |
80,427
+50,217
| +166% | +$1.79M | ﹤0.01% | 1476 |
|
2023
Q3 | $898K | Buy |
30,210
+7,125
| +31% | +$212K | ﹤0.01% | 1768 |
|
2023
Q2 | $416K | Sell |
23,085
-15,234
| -40% | -$275K | ﹤0.01% | 2453 |
|
2023
Q1 | $615K | Buy |
38,319
+9,062
| +31% | +$146K | ﹤0.01% | 2374 |
|
2022
Q4 | $535K | Buy |
29,257
+7,736
| +36% | +$142K | ﹤0.01% | 2408 |
|
2022
Q3 | $423K | Sell |
21,521
-3,442
| -14% | -$67.7K | ﹤0.01% | 2456 |
|
2022
Q2 | $466K | Sell |
24,963
-1,330
| -5% | -$24.8K | ﹤0.01% | 2633 |
|
2022
Q1 | $577K | Sell |
26,293
-2,978
| -10% | -$65.4K | ﹤0.01% | 2649 |
|
2021
Q4 | $832K | Sell |
29,271
-60,785
| -67% | -$1.73M | ﹤0.01% | 2534 |
|
2021
Q3 | $1.9M | Buy |
90,056
+970
| +1% | +$20.4K | ﹤0.01% | 2134 |
|
2021
Q2 | $1.68M | Buy |
89,086
+4,120
| +5% | +$77.6K | ﹤0.01% | 2385 |
|
2021
Q1 | $1.3M | Buy |
84,966
+64,495
| +315% | +$985K | ﹤0.01% | 2493 |
|
2020
Q4 | $289K | Buy |
20,471
+5,044
| +33% | +$71.2K | ﹤0.01% | 3209 |
|
2020
Q3 | $242K | Buy |
15,427
+1,306
| +9% | +$20.5K | ﹤0.01% | 3083 |
|
2020
Q2 | $247K | Buy |
14,121
+10,323
| +272% | +$181K | ﹤0.01% | 2997 |
|
2020
Q1 | $56K | Sell |
3,798
-222
| -6% | -$3.27K | ﹤0.01% | 3419 |
|
2019
Q4 | $100K | Buy |
4,020
+919
| +30% | +$22.9K | ﹤0.01% | 3507 |
|
2019
Q3 | $45K | Sell |
3,101
-177
| -5% | -$2.57K | ﹤0.01% | 3866 |
|
2019
Q2 | $81K | Sell |
3,278
-6,068
| -65% | -$150K | ﹤0.01% | 4155 |
|
2019
Q1 | $210K | Buy |
9,346
+2,500
| +37% | +$56.2K | ﹤0.01% | 3886 |
|
2018
Q4 | $203K | Sell |
6,846
-8,914
| -57% | -$264K | ﹤0.01% | 3772 |
|
2018
Q3 | $451K | Buy |
+15,760
| New | +$451K | ﹤0.01% | 3783 |
|